A new study published in Endocrine-Related Cancer which used data from the OCRF-funded Ovarian Cancer Association Consortium, evaluated the association between BMI and ovarian cancer risk, and also examined the association by histological subtype, menopausal status, and post-menopausal hormone (HRT) use.
Results showed that while obesity does appear to increase risk of less common types of ovarian cancer, it does not increase the risk of the most common and deadly type, high-grade invasive serous ovarian cancers. Therefore, reducing BMI is unlikely to prevent the majority of ovarian cancer deaths.
For complete results of the study, click here to read the abstract.
